Related references
Note: Only part of the references are listed.Metformin induces degradation of cyclin D1 via AMPK/GSK3 axis in ovarian cancer
HyeRan Gwak et al.
MOLECULAR CARCINOGENESIS (2017)
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
Susanne Schueler-Toprak et al.
BMC CANCER (2017)
Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro
Susanne Schueler-Toprak et al.
BMC CANCER (2016)
Understanding genistein in cancer: The good and the bad effects: A review
Maria Russo et al.
FOOD CHEMISTRY (2016)
Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway
Ye-Seul Kim et al.
PHYTOMEDICINE (2015)
Genistein and Cancer: Current Status, Challenges, and Future Directions
Carmela Spagnuolo et al.
ADVANCES IN NUTRITION (2015)
Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells
Yongjian Li et al.
ONCOLOGY REPORTS (2015)
PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
HaiXia Li et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Erb-041, an Estrogen Receptor-β Agonist, Inhibits Skin Photocarcinogenesis in SKH-1 Hairless Mice by Downregulating the WNT Signaling Pathway
Sandeep C. Chaudhary et al.
CANCER PREVENTION RESEARCH (2014)
Targeting Estrogen Receptor-β for the Prevention of Nonmelanoma Skin Cancer
Pei-Li Yao et al.
CANCER PREVENTION RESEARCH (2014)
Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer
Weifeng Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer
Karen Kar-Loen Chan et al.
JOURNAL OF ENDOCRINOLOGY (2014)
7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1
Ying-Xia Ning et al.
ONCOLOGY LETTERS (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
Isoflavones: estrogenic activity, biological effect and bioavailability
Daniela Cristina Vitale et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2013)
Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells
Hyun Jin Park et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M. K. Y. Siu et al.
ONCOGENE (2013)
Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway
Panhong Fan et al.
STEM CELL RESEARCH & THERAPY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Hormone response in ovarian cancer: time to reconsider as a clinical target?
Francesmary Modugno et al.
ENDOCRINE-RELATED CANCER (2012)
Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
Carine Bossard et al.
PLOS ONE (2012)
Cancer stem cells: an evolving concept
Long V. Nguyen et al.
NATURE REVIEWS CANCER (2012)
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis
Xiaofeng Zhao et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
TARGETING THE AKT/GSK3β/CYCLIN D1/CDK4 SURVIVAL SIGNALING PATHWAY FOR ERADICATION OF TUMOR RADIORESISTANCE ACQUIRED BY FRACTIONATED RADIOTHERAPY
Tsutomu Shimura et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Development of subtype-selective oestrogen receptor-based therapeutics
Stefan Nilsson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway
S. Jin et al.
ANNALS OF ONCOLOGY (2010)
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
Michelle K. Y. Siu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways
Gaoliang Ouyang et al.
CELL BIOLOGY INTERNATIONAL (2009)
MEK4 Function, Genistein Treatment, and Invasion of Human Prostate Cancer Cells
Li Xu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
Yan Gu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Estrogen receptors α and β as determinants of gene expression:: Influence of ligand, dose, and chromatin binding
Edmund C. Chang et al.
MOLECULAR ENDOCRINOLOGY (2008)
Estrogen receptor subtypes in ovarian cancer - A clinical correlation
Karen K. L. Chan et al.
OBSTETRICS AND GYNECOLOGY (2008)
Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation
Ismail Ahmed Ismail et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Estrogen receptor beta 1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells
Oliver Treeck et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-β ligands
MS Malamas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Soy and isoflavone intake are associated with reduced risk of ovarian cancer in Southeast China
M Zhang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1
F Casagrande et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Share Paper
